Cargando…
A Case Report on Aggressive Natural Killer Cell Leukemia in a Pediatric Patient
Aggressive natural killer cell leukemia (ANKL) is a rare neoplastic malignancy, especially in pediatric populations with very few cases reported in the literature. It commonly presents with a rapidly declining clinical course and has a median survival of two months. We report the case of a 15-year-o...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250800/ https://www.ncbi.nlm.nih.gov/pubmed/35795499 http://dx.doi.org/10.7759/cureus.25634 |
_version_ | 1784739879652950016 |
---|---|
author | Donato, Umberto M Shoeleh, Celeste Galligan, Andrew |
author_facet | Donato, Umberto M Shoeleh, Celeste Galligan, Andrew |
author_sort | Donato, Umberto M |
collection | PubMed |
description | Aggressive natural killer cell leukemia (ANKL) is a rare neoplastic malignancy, especially in pediatric populations with very few cases reported in the literature. It commonly presents with a rapidly declining clinical course and has a median survival of two months. We report the case of a 15-year-old female who presented with fever, hepatosplenomegaly, hemophagocytosis, and disseminated intravascular coagulation (DIC). The patient was ultimately diagnosed with ANKL but died after developing multiorgan failure and DIC prior to the initiation of any treatment. In this case report, we review and discuss the literature concerning the diagnosis and treatment of ANKL in pediatric patients. |
format | Online Article Text |
id | pubmed-9250800 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-92508002022-07-05 A Case Report on Aggressive Natural Killer Cell Leukemia in a Pediatric Patient Donato, Umberto M Shoeleh, Celeste Galligan, Andrew Cureus Pediatrics Aggressive natural killer cell leukemia (ANKL) is a rare neoplastic malignancy, especially in pediatric populations with very few cases reported in the literature. It commonly presents with a rapidly declining clinical course and has a median survival of two months. We report the case of a 15-year-old female who presented with fever, hepatosplenomegaly, hemophagocytosis, and disseminated intravascular coagulation (DIC). The patient was ultimately diagnosed with ANKL but died after developing multiorgan failure and DIC prior to the initiation of any treatment. In this case report, we review and discuss the literature concerning the diagnosis and treatment of ANKL in pediatric patients. Cureus 2022-06-03 /pmc/articles/PMC9250800/ /pubmed/35795499 http://dx.doi.org/10.7759/cureus.25634 Text en Copyright © 2022, Donato et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Pediatrics Donato, Umberto M Shoeleh, Celeste Galligan, Andrew A Case Report on Aggressive Natural Killer Cell Leukemia in a Pediatric Patient |
title | A Case Report on Aggressive Natural Killer Cell Leukemia in a Pediatric Patient |
title_full | A Case Report on Aggressive Natural Killer Cell Leukemia in a Pediatric Patient |
title_fullStr | A Case Report on Aggressive Natural Killer Cell Leukemia in a Pediatric Patient |
title_full_unstemmed | A Case Report on Aggressive Natural Killer Cell Leukemia in a Pediatric Patient |
title_short | A Case Report on Aggressive Natural Killer Cell Leukemia in a Pediatric Patient |
title_sort | case report on aggressive natural killer cell leukemia in a pediatric patient |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250800/ https://www.ncbi.nlm.nih.gov/pubmed/35795499 http://dx.doi.org/10.7759/cureus.25634 |
work_keys_str_mv | AT donatoumbertom acasereportonaggressivenaturalkillercellleukemiainapediatricpatient AT shoelehceleste acasereportonaggressivenaturalkillercellleukemiainapediatricpatient AT galliganandrew acasereportonaggressivenaturalkillercellleukemiainapediatricpatient AT donatoumbertom casereportonaggressivenaturalkillercellleukemiainapediatricpatient AT shoelehceleste casereportonaggressivenaturalkillercellleukemiainapediatricpatient AT galliganandrew casereportonaggressivenaturalkillercellleukemiainapediatricpatient |